MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Validation Study of the Parkinson’s Disease Stigma Questionnaire (PDStigmaQuest)

V. Stopic, S. Jost, J. Haupt, G. Brandt, C. Vander Linden, JN. Petry-Schmelzer, T. Dembek, G. Fink, L. Batzu, A. Rizos, R. Chaudhuri, H. Dafsari, D. Gruber, G. Ebersbach, J. Kessler, M. Barbe, A. Sauerbier (Cologne, Germany)

Meeting: 2024 International Congress

Abstract Number: 493

Keywords: Parkinson’s, Scales

Category: Rating Scales

Objective: To test the psychometric properties of the newly developed Parkinson’s Disease Stigma Questionnaire (PDStigmaQuest).

Background: Stigma is a significant aspect of Parkinson’s disease (PD). However, there is currently no specific tool available to assess and evaluate the complex construct of stigma in PD.

Method: This multi-center, cross-sectional study included PD patients and healthy controls. The dimensionality of the PDStigmaQuest was examined through exploratory factor analysis. Acceptability and psychometric properties were analyzed. PDStigmaQuest scores of patients and healthy controls were compared.

Results: In total, 201 PD patients and 101 healthy controls were included in the final analysis. Results suggested high data quality with 0.0001 % missing data in the PDStigmaQuest for PD patients and no missing data for controls. The exploratory factor analysis produced four factors: felt stigma, hiding, enacted stigma: rejection, and enacted stigma: patronization, explaining 47.9 % of variance. An optional domain for employed patients was included. Moderate floor effects and skewness, but no ceiling effects were found. Cronbach’s alpha of 0.85 indicated high internal consistency. Test-retest reliability was high (rs = 0.83). PDStigmaQuest scores correlated significantly with other stigma measures (rs = 0.56-0.69) and were significantly higher in patients with depressive symptoms than in those without.

Conclusion: The new patient-completed, 18-item PDStigmaQuest showed strong psychometric properties of validity and reliability. The results suggest that the PDStigmaQuest can be used to assess and evaluate stigma comprehensively in PD, which will help to understand further the construct of PD stigma.

To cite this abstract in AMA style:

V. Stopic, S. Jost, J. Haupt, G. Brandt, C. Vander Linden, JN. Petry-Schmelzer, T. Dembek, G. Fink, L. Batzu, A. Rizos, R. Chaudhuri, H. Dafsari, D. Gruber, G. Ebersbach, J. Kessler, M. Barbe, A. Sauerbier. Validation Study of the Parkinson’s Disease Stigma Questionnaire (PDStigmaQuest) [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/validation-study-of-the-parkinsons-disease-stigma-questionnaire-pdstigmaquest/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/validation-study-of-the-parkinsons-disease-stigma-questionnaire-pdstigmaquest/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley